Infectious Diseases

The American Academy of Pediatrics (AAP) has updated their guidance on participating in sports during the COVID-19 pandemic.

Following the green light from the vaccine advisory committee, the US Food and Drug Administration has given emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, making it the first vaccine for COVID-19 approved for use in the United States.

The US Food and Drug Administration (FDA) vaccine committee has given the green light to the the Pfizer/BioNTech vaccine, meaning approval may happen in a matter of days.

Multisystem inflammatory syndrome in children (MIS-C) is a serious consequence of COVID-19. Is the risk of it equal to all children or does race/ethnicity play a role?

A teenager shares how students can connect, even in the COVID era.

CDC guidelines to keep you and your practice safe from COVID-19 infection.

Despite public health agencies warning against gathering for Thanksgiving, many families are still planning to do so. A new poll offers some insight on why parents still plan to gather and what they are doing to try to keep everyone safe.

A new study examines the epidemiology of pediatric COVID-19 cases in a large cohort.

Infectious Disease Society of America offered a look at the current treatment options for COVID-19 and stressed the need to maintain precautions to keep people safe.

The debate over schools re-opening during the pandemic hasn’t abated and isn’t likely to with the start of a third wave. A model offers insight into how the school disruptions may impact the life expectancy of the affected children.

Dr. Tan shares her 3 must read articles in the November 2020 issue of Contemporary Pediatrics.

The hepatitis B vaccine represents the best way to prevent the disease, which has no cure. An investigation looks at how long vaccine-linked immunity might last.

A presentation at the virtual 2020 American Academy of Pediatrics National Conference & Exhibition offered a case-based format to highlight several important clinical pearls relating to optimizing antimicrobial use in the outpatient and inpatient pediatrics settings.

Recommendations on the diagnosis and management of community-acquired pneumonia.

Dermatologic findings in the age of COVID-19, plus lots more at the 2020 American Academy of Pediatrics National Conference & Exhibition.

Vaccine hesitancy has led to reductions in many childhood vaccines. A report offers insight into how it impacts influenza vaccination.

Pfizer and BioNTech have released interim information on their Phase 3 COVID-19 vaccine trial.

Are targeted screenings for sexually transmitted infections (STIs) or universally offered screenings more cost effective than not screening? An investigation offers some answers.

The impact of COVID-19 on mental health is hard to measure. A report offers a look at how quarantine impacted the mental health of university students.

Breastfeeding has a number of positive influences on a child. Is reducing infections one them?

COVID-19 has created many stresses: mental, job-related, and health. For some caregivers, these stressors are complicated further with caring for a child with attention-deficit/hyperactive disorder (ADHD).

With a rise in vaccine hesitancy, it’s more important than ever to have strong vaccine adherence. A poster at the virtual 2020 ID Week looks at how vaccine type can impact diphtheria, tetanus, and acellular pertussis (DTaP) vaccination.

As more children return to the pediatric office, the need to create safety protocols is imperative. The American Academy of Pediatrics (AAP) has created guidance for developing them.

Overall, COVID-19 is disproportionately impacting minority populations in the United States. A report examines if this holds true in the pediatric population.

The influenza vaccine has been recommended as a key way to reduce severe influenza in children. An investigation examines how effective the 2018-2019 vaccine was in preventing hospitalization and emergency department visits.